A detailed history of Quadrant Capital Group LLC transactions in Orasure Technologies Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 720 shares of OSUR stock, worth $2,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
720
Previous 1,072 32.84%
Holding current value
$2,606
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.93 - $4.59 $1,383 - $1,615
-352 Reduced 32.84%
720 $3,000
Q1 2024

May 15, 2024

SELL
$6.08 - $8.28 $899 - $1,225
-148 Reduced 12.13%
1,072 $6,000
Q3 2023

Nov 14, 2023

SELL
$4.4 - $6.91 $2,939 - $4,615
-668 Reduced 35.38%
1,220 $7,000
Q1 2023

May 11, 2023

SELL
$4.66 - $6.52 $1,901 - $2,660
-408 Reduced 17.77%
1,888 $11,000
Q4 2022

Feb 10, 2023

BUY
$3.7 - $5.29 $4,710 - $6,734
1,273 Added 124.44%
2,296 $11,000
Q3 2022

Nov 10, 2022

BUY
$2.72 - $4.61 $2,535 - $4,296
932 Added 1024.18%
1,023 $4,000
Q2 2022

Aug 09, 2022

SELL
$2.71 - $7.12 $54 - $142
-20 Reduced 18.02%
91 $0
Q1 2022

May 06, 2022

SELL
$6.62 - $9.33 $191 - $270
-29 Reduced 20.71%
111 $1,000
Q3 2021

Nov 12, 2021

SELL
$9.73 - $13.38 $642 - $883
-66 Reduced 32.04%
140 $2,000
Q2 2021

Aug 09, 2021

SELL
$9.02 - $11.68 $1,885 - $2,441
-209 Reduced 50.36%
206 $2,000
Q1 2021

May 12, 2021

BUY
$9.53 - $15.42 $2,201 - $3,562
231 Added 125.54%
415 $5,000
Q1 2020

May 15, 2020

SELL
$5.57 - $10.76 $5,035 - $9,727
-904 Reduced 83.09%
184 $2,000
Q3 2019

Oct 24, 2019

BUY
$6.57 - $9.46 $7,148 - $10,292
1,088 New
1,088 $8,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $263M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.